The dual-luciferase reporter assay confirmed that miR-204-5p has binding sites with ADAM15, and miR-204-5p can inhibit ADAM15-induced proliferation of NSCLC, which further confirms the tumour promoting function of ADAM15 and provides more clues to the regulation network of ADAM15. The gene discussed is ADAM15; the disease is non-small cell lung carcinoma.